Intervirology 2004;47:289–309
(DOI:10.1159/000080872)

Genetic Diversity of Hepatitis B Virus Strains Derived Worldwide: Genotypes, Subgenotypes, and HBsAg Subtypes

Norder H.a · Couroucé A.-M.e · Coursaget P.c · Echevarria J.M.d · Lee S.-D.f · Mushahwar I.K.g · Robertson B.H.h · Locarnini S.b · Magnius L.O.a
aSwedish Institute for Infectious Disease Control, Solna, Sweden; bVictorian Infectious Diseases and Centre for Clinical Research Excellence in Infectious Diseases, Royal Melbourne Hospital, Melbourne, Australia; cLaboratoire de Virologie Moléculaire, INSERM U618, IFR 136 Agents Transmissibles et Infectiologie, Faculté des Sciences Pharmaceutiques Ph. Maupas, Tours, France; dService of Diagnostic Microbiology, National Centre for Microbiology, Instituto de Salud Carlos III, Madrid, Spain; eUnité de Virologie Transfusionnelle, Institut National de la Transfusion Sanguine, Paris, France; fDepartment of Medicine, Taipei Veterans General Hospital and National Yang-Ming University School of Medicine, Taipei, Taiwan, and gCore Research and Development, Infectious Disease Group, Abbott Laboratories, Abbott Park, Ill., and hDivision of Viral Hepatitis A33, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Ga., USA
email Corresponding Author


 goto top of outline Key Words

  • Genotypes
  • Subgenotypes
  • Subtypes
  • Molecular epidemiology
  • Evolution
  • Non-human primates

 goto top of outline Abstract

Sequences of 234 complete genomes and 631 hepatitis B surface antigen genes were used to assess the worldwide diversity of hepatitis B virus (HBV). Apart from the described two subgenotypes each for A and F, also B, C, and D divided into four subgenotypes each in the analysis of complete genomes supported by significant bootstrap values. The subgenotypes of B and C differed in their geographical distribution, with B1 dominating in Japan, B2 in China and Vietnam, B3 confined to Indonesia, and B4 confined to Vietnam, all strains specifying subtype ayw1. Subgenotype C1 was common in Japan, Korea, and China; C2 in China, South-East Asia, and Bangladesh, and C3 in the Oceania comprising strains specifying adrq–, and C4 specifying ayw3 is encountered in Aborigines from Australia. This pattern of defined geographical distribution was less evident for D1–D4, where the subgenotypes were widely spread in Europe, Africa, and Asia, possibly due to their divergence having occurred a longer time ago than for genotypes B and C, with D4 being the first split and still the dominating subgenotype of D in the Oceania. The genetic diversity of HBV and the geographical distribution of its subgenotypes provide a tool to reconstruct the evolutionary history of HBV and may help to complement genetic data in the understanding of the evolution and past migrations of man.

Copyright © 2004 S. Karger AG, Basel


 goto top of outline References
  1. Okamoto H, Tsuda F, Sakugawa H, Sastrosoewignjo RI, Imai M, Miyakawa Y, Mayumi M: Typing hepatitis B virus by homology in nucleotide sequence: Comparison of surface antigen subtypes. J Gen Virol 1988;69:2575–2583.
  2. Norder H, Hammas B, Löfdahl S, Couroucé AM, Magnius LO: Comparison of the amino acid sequences of nine different serotypes of hepatitis B surface antigen and genomic classification of the corresponding hepatitis B virus strains. J Gen Virol 1992;73:1201–1208.
  3. Norder H, Couroucé AM, Magnius LO: Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology 1994;198:489–503.
  4. Naumann H, Schaefer S, Yoshida CF, Gaspar AM, Repp R, Gerlich WH: Identification of a new hepatitis B virus (HBV) genotype from Brazil that expresses HBV surface antigen subtype adw4. J Gen Virol 1993;74:1627–1632.
  5. Stuyver L, De Gendt S, Van Geyt C, Zoulim F, Fried M, Schinazi RF, Rossau R: A new genotype of hepatitis B virus: Complete genome and phylogenetic relatedness. J Gen Virol 2000;81:67–74.
  6. Arauz-Ruiz P, Norder H, Robertson BH, Magnius LO: Genotype H: A new Amerindian genotype of hepatitis B virus revealed in Central America. J Gen Virol 2002;83:2059–2073.
  7. Kramvis A, Weitzmann L, Owiredu WK, Kew MC: Analysis of the complete genome of subgroup A’ hepatitis B virus isolates from South Africa. J Gen Virol 2002;83:835–839.
  8. Kimbi GC, Kramvis A, Kew MC: Distinctive sequence characteristics of subgenotype A1 isolates of hepatitis B virus from South Africa. J Gen Virol 2004;85:1211–1220.
  9. Norder H, Arauz-Ruiz P, Blitz L, Pujol FH, Echevarria JM, Magnius LO: The T(1858) variant predisposing to the precore stop mutation correlates with one of two major genotype F hepatitis B virus clades. J Gen Virol 2003;84:2083–2087.
  10. Okamoto H, Imai M, Tsuda F, Tanaka T, Miyakawa Y, Mayumi M: Point mutation in the S gene of hepatitis B virus for a d/y or w/r subtypic change in two blood donors carrying a surface antigen of compound subtype adyr or adwr. J Virol 1987;61:3030–3034.
  11. Norder H, Couroucé AM, Magnius LO: Molecular basis of hepatitis B virus serotype variations within the four major subtypes. J Gen Virol 1992;73:3141–3145.
  12. Magnius LO, Kaplan L, Vyas GN, Perkins HA: A new virus specified determinant of hepatitis B surface antigen. Acta Pathol Microbiol Scand [B] 1975;83:295–297.
  13. Couroucé-Pauty AM, Lemaire JM, Roux JF: New hepatitis B surface antigen inside the ad category. Vox Sang 1978;27:533–549.
  14. Norder H, Ebert JW, Fields HA, Mushahwar IK, Magnius LO: Complete sequencing of a gibbon hepatitis B virus genome reveals a unique genotype distantly related to the chimpanzee hepatitis B virus. Virology 1996;218:214–223.
  15. Norder H, Hammas B, Lee SD, Couroucé AM, Mushahwar IK, Magnius LO: Genetic relatedness of hepatitis B viral strains with diverse geographic origin and natural variations in the primary structure of hepatitis B surface antigen. J Gen Virol 1993;74:1341–1348.
  16. Felsenstein J: PHYLIP: Phylogeny Inference Package, version 3.52c. Seattle, University of Washington, 1993.
  17. Arauz-Ruiz P, Norder H, Visona KA, Magnius LO: Molecular epidemiology of hepatitis B virus in Central America reflected in the genetic variability of the small S gene. J Infect Dis 1997;176:851–858.
  18. Stuyver LJ, Locarnini SA, Lok A, Richman DD, Carman WF, Dienstag JL, Schinazi RF: Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region. Hepatology 2001;33:751–757.
  19. Bowyer SM, van Staden L, Kew MC, Sim JGM: A unique segment of the hepatitis B virus group A genotype identified in isolates from South Africa. J Gen Virol 1997;78:1719–1729.
  20. Owiredu WK, Kramvis A, Kew MC: Molecular analysis of hepatitis B virus genomes isolated from black African patients with fulminant hepatitis B. J Med Virol 2001;65:485–492.
  21. Vaudin M, Wolstenholme AJ, Tsiquaye KN, Zuckerman AJ, Harrison TJ: The complete nucleotide sequence of the genome of a hepatitis B virus isolated from a naturally infected chimpanzee. J Gen Virol 1988;69:1383–1389.
  22. Sugauchi F, Orito E, Ichida T, Kato H, Sakugawa H, Kakumu S, Ishida T, Chutaputti A, Lai CL, Ueda R, Miyakawa Y, Mizokami M: Hepatitis B virus of genotype B with or without recombination with genotype C over the precore region plus the core gene. J Virol 2002;76:5985–5992.
  23. Sugauchi F, Kumada H, Sakugawa H, Komatsu M, Niitsuma H, Watanabe H, Akahane Y, Tokita H, Kato T, Tanaka Y, Orito E, Ueda R, Miyakawa Y, Mizokami M: Two subtypes of genotype B (Ba and Bj) of hepatitis B virus in Japan. Clin Infect Dis 2004;38:1222–1228.
  24. Sugauchi F, Mizokami M, Orito E, Ohno T, Kato H, Suzuki S, Kimura Y, Ueda R, Butterworth LA, Cooksley WG: A novel variant genotype C of hepatitis B virus identified in isolates from Australian Aborigines: Complete genome sequence and phylogenetic relatedness. J Gen Virol 2001;82:883–892.
  25. Cui C, Shi J, Hui L, Xi H, Zhuoma, Quni, Tsedan, Hu G: The dominant hepatitis B virus genotype identified in Tibet is a C/D hybrid. J Gen Virol 2002;83:2773–2777.
  26. Krugman S, Giles JP, Hammond J: Viral hepatitis, type B (MS-2 strain) prevention with specific hepatitis B immune serum globulin. JAMA 1971;218:1665–1670.
  27. Takahashi K, Brotman B, Usuda S, Mishiro S, Prince AM: Full-genome sequence analyses of hepatitis B virus (HBV) strains recovered from chimpanzees infected in the wild: Implications for an origin of HBV. Virology 2000;267:58–64.
  28. Couroucé-Pauty AM, Plancon A, Soulier JP: Distribution of HBsAg subtypes in the world. Vox Sang 1983;44:197–211.
  29. Grethe S, Heckel JO, Rietschel W, Hufert FT: Molecular epidemiology of hepatitis B virus variants in nonhuman primates. J Virol 2000;74:5377–5381.
  30. Couroucé AM, Drouet J, Muller JY: HBs antigen subtypes. Bibl Haematol 1976;42:89–127.
  31. Stirk HJ, Thornton JM, Howard CR: A topological model for hepatitis B surface antigen. Intervirology 1992;33:148–158.
  32. Jilg W: Novel hepatitis B vaccines. Vaccine 1998;16 Suppl:S65–S68.

    External Resources

  33. Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ, Thomas HC: Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990;336:325–329.
  34. Carman WF, Trautwein C, van Deursen FJ, Colman K, Dornan E, McIntyre G, Waters J, Kliem V, Muller R, Thomas HC, Manns MP: Hepatitis B virus envelope variation after transplantation with and without hepatitis immune globulin prophylaxis. Hepatology 1996;24:489–493.
  35. Huo J, Wang Z, Chen J, Lin Y, Lau GK, Sun J, Waters J, Karayiannis P, Luo K: Prevalence of naturally occurring surface gene variants of hepatitis B virus in non-immunized surface antigen-negative Chinese carriers. Hepatology 2001;34:1–16.
  36. Chirara MM, Chetsanga CJ: Variant of hepatitis B virus isolated in Zimbabwe. J Med Virol 1994;42:73–78.
  37. Karthigesu VD, Allison LM, Fortuin M, Mendy M, Whittle HC, Howard CR: A novel hepatitis B virus variant in the sera of immunized children. J Gen Virol 1994;75(Pt 2):443–448.
  38. Tipples GA, Ma MM, Fischer KP, Bain VG, Kneteman NM, Tyrrell DL: Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology 1996;24:714–717.
  39. Lai CL, Chien RN, Leung NW, Chang TT, Guan R, Tai DI, Ng KY, Wu PC, Dent JC, Barber J, Stephenson SL, Gray DF: A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. N Engl J Med 1998;339:61–68.
  40. Dienstag JL, Schiff ER, Wright TL, Perrillo RP, Hann HW, Goodman Z, Crowther L, Condreay LD, Woessner M, Rubin M, Brown NA: Lamivudine as initial treatment for chronic hepatitis B in the United States. N Engl J Med 1999;341:1256–1263.
  41. Zöllner B, Petersen J, Schröter M, Laufs R, Schoder V, Feucht HH: 20-fold increase in risk of lamivudine resistance in hepatitis B virus subtype adw. Lancet 2001;357:934–935.
  42. Kao JH, Liu CJ, Chen DS: Hepatitis B viral genotypes and lamivudine resistance. J Hepatol 2002;36:303–305.
  43. Suzuki F, Tsubota A, Arase Y, Suzuki Y, Akuta N, Hosaka T, Someya T, Kobayashi M, Saitoh S, Ikeda K, Kobayashi M, Matsuda M, Satoh J, Takagi K, Kumada H: Efficacy of lamivudine therapy and factors associated with emergence of resistance in chronic hepatitis B virus infection in Japan. Intervirology 2003;46:182–189.
  44. Leon P, Pozo F, Echevarria JM: Detection of hepatitis B virus variants resistant to lamivudine and famciclovir among randomly selected chronic carriers from Spain. Enferm Infecc Microbiol Clin 2004;22:133–137.
  45. Bozdayi AM, Uzunalimoglu O, Turkyilmaz AR, Aslan N, Sezgin O, Sahin T, Bozdayi G, Cinar K, Pai SB, Pai R, Bozkaya H, Karayalcin S, Yurdaydin C, Schinazi RF: YSDD: A novel mutation in HBV DNA polymerase confers clinical resistance to lamivudine. J Viral Hepat 2003;10:256–265.
  46. Westland C, Delaney W 4th, Yang H, Chen SS, Marcellin P, Hadziyannis S, Gish R, Fry J, Brosgart C, Gibbs C, Miller M, Xiong S: Hepatitis B virus genotypes and virologic response in 694 patients in phase III studies of adefovir dipivoxil1. Gastroenterology 2003;125:107–116.
  47. Mayerat C, Mantegani A, Frei PC: Does hepatitis B virus (HBV) genotype influence the clinical outcome of HBV infection? J Viral Hepat 1999;6:299–304.
  48. Kobayashi M, Arase Y, Ikeda K, Tsubota A, Suzuki Y, Saitoh S, Kobayashi M, Suzuki F, Akuta N, Someya T, Matsuda M, Sato J, Takagi K, Miyakawa Y, Kumada H: Viral genotypes and response to interferon in patients with acute prolonged hepatitis B virus infection in adulthood in Japan. J Med Virol 2002;68:522–528.
  49. Shafritz DA, Shouval D, Sherman HI, Hadziyannis SJ, Kew MC: Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma: Studies in percutaneous liver biopsies and post-mortem tissue specimens. N Engl J Med 1981;305:1067–1073.
  50. Tiollais P, Buendia MA: Hepatitis B virus. Sci Am 1991;264:116–123.
  51. Sugauchi F, Chutaputti A, Orito E, Kato H, Suzuki S, Ueda R, Mizokami M: Hepatitis B virus genotypes and clinical manifestation among hepatitis B carriers in Thailand. J Gastroenterol Hepatol 2002;17:671–676.
  52. Ishikawa K, Koyama T, Masuda T: Prevalence of HBV genotypes in asymptomatic carrier residents and their clinical characteristics during long-term follow-up: The relevance to changes in the HBeAg/anti-HBe system. Hepatol Res 2002;24:1.
  53. Chu CJ, Hussain M, Lok AS: Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C. Gastroenterology 2002;122:1756–1762.
  54. Thakur V, Guptan RC, Kazim SN, Malhotra V, Sarin SK: Profile, spectrum and significance of HBV genotypes in chronic liver disease patients in the Indian subcontinent. J Gastroenterol Hepatol 2002;17:165–170.
  55. Lee CM, Chen CH, Lu SN, Tung HD, Chou WJ, Wang JH, Chen TM, Hung CH, Huang CC, Chen WJ: Prevalence and clinical implications of hepatitis B virus genotypes in southern Taiwan. Scand J Gastroenterol 2003;38:95–101.
  56. Sumi H, Yokosuda O, Seki N, Arai M, Imazeki F, Kurihara T, Kanda T, Fukai K, Kato M, Saiso H: Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease. Hepatology 2003;37:19–26.
  57. Tsubota A, Arase Y, Ren F, Tanaka H, Ikeda K, Kumada H: Genotype may correlate with liver carcinogenesis and tumor characteristics in cirrhotic patients infected with hepatitis B virus subtype adw. J Med Virol 2001;65:257–265.
  58. Kao JH, Chen PJ, Lai MY, Chen DS: Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology 2000;118:554–559.
  59. Sanchez-Tapias JM, Costa J, Mas A, Bruguera M, Rodes J: Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in western patients. Gastroenterology 2002;123:1848–1856.
  60. Casey JL, Niro GA, Engle RE, Vega A, Gomez H, McCarthy M, Watts DM, Hyams KC, Gerin JL: Hepatitis B virus (HBV)/hepatitis D virus (HDV) coinfection in outbreaks of acute hepatitis in the Peruvian Amazon basin: The roles of HDV genotype III and HBV genotype F. J Infect Dis 1996;174:920–926.
  61. Valenzuela P, Quiroga M, Zalvidar J, Gray P, Rutter WJ: The nucleotide sequence of the hepatitis B viral genome and the identification of the major viral genes; in Fields BN, Jaenisch R, Fox CF (eds): Animal Virus Genetics. New York, Academic Press, 1980, pp 57–70.

 goto top of outline Author Contacts

Helene Norder, PhD
Swedish Institute for Infectious Disease Control
SE–171 82 Solna (Sweden)
Tel. +46 8 457 2638, Fax +46 8 340 855
E-Mail helene.norder@smi.ki.se


 goto top of outline Article Information

Received: June 6, 2004
Accepted: July 22, 2004
Number of Print Pages : 21
Number of Figures : 6, Number of Tables : 1, Number of References : 61


 goto top of outline Publication Details

Intervirology (International Journal of Basic and Medical Virology)

Vol. 47, No. 6, Year 2004 (Cover Date: 2004)

Journal Editor: U.G. Liebert, Leipzig
ISSN: 0300–5526 (print), 1423–0100 (Online)

For additional information: http://www.karger.com/int


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.